FMED vs. FSMEX
Compare and contrast key facts about Fidelity Disruptive Medicine ETF (FMED) and Fidelity Select Medical Technology and Devices Portfolio (FSMEX).
FMED is an actively managed fund by Fidelity. It was launched on Apr 16, 2020. FSMEX is managed by Fidelity. It was launched on Apr 28, 1998.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: FMED or FSMEX.
Correlation
The correlation between FMED and FSMEX is 0.87, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
FMED vs. FSMEX - Performance Comparison
Key characteristics
FMED:
0.29
FSMEX:
-0.01
FMED:
0.50
FSMEX:
0.09
FMED:
1.06
FSMEX:
1.01
FMED:
0.51
FSMEX:
-0.01
FMED:
1.08
FSMEX:
-0.04
FMED:
4.02%
FSMEX:
5.13%
FMED:
15.18%
FSMEX:
16.52%
FMED:
-21.84%
FSMEX:
-43.45%
FMED:
-1.82%
FSMEX:
-26.14%
Returns By Period
The year-to-date returns for both investments are quite close, with FMED having a 5.93% return and FSMEX slightly higher at 6.11%.
FMED
5.93%
3.17%
2.35%
4.94%
N/A
N/A
FSMEX
6.11%
0.86%
0.14%
0.18%
0.94%
5.83%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FMED vs. FSMEX - Expense Ratio Comparison
FMED has a 0.50% expense ratio, which is lower than FSMEX's 0.68% expense ratio.
Risk-Adjusted Performance
FMED vs. FSMEX — Risk-Adjusted Performance Rank
FMED
FSMEX
FMED vs. FSMEX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Disruptive Medicine ETF (FMED) and Fidelity Select Medical Technology and Devices Portfolio (FSMEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
FMED vs. FSMEX - Dividend Comparison
FMED's dividend yield for the trailing twelve months is around 0.43%, while FSMEX has not paid dividends to shareholders.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FMED Fidelity Disruptive Medicine ETF | 0.43% | 0.46% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
FSMEX Fidelity Select Medical Technology and Devices Portfolio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.18% | 0.00% | 11.71% | 5.17% |
Drawdowns
FMED vs. FSMEX - Drawdown Comparison
The maximum FMED drawdown since its inception was -21.84%, smaller than the maximum FSMEX drawdown of -43.45%. Use the drawdown chart below to compare losses from any high point for FMED and FSMEX. For additional features, visit the drawdowns tool.
Volatility
FMED vs. FSMEX - Volatility Comparison
Fidelity Disruptive Medicine ETF (FMED) has a higher volatility of 4.30% compared to Fidelity Select Medical Technology and Devices Portfolio (FSMEX) at 4.00%. This indicates that FMED's price experiences larger fluctuations and is considered to be riskier than FSMEX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.